ly 300164 has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chimirri, A; De Sarro, A; De Sarro, G; Ferreri, G; Gitto, R; Orlando, V; Quartarone, S; Russo, E | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bendotti, C; Engelhardt, JI; Obál, I; Paizs, M; Patai, R; Siklós, L; Tortarolo, M | 1 |
| Aujla, PK; Fetell, MR; Jensen, FE | 1 |
| Andrási, F; Berzsenyi, P; Erdo, F | 1 |
| Barkoczy, J; Gigler, G; Gressens, P; Harsing, LG; Kapus, G; Kertesz, S; Levay, G; Medja, F; Spedding, M; Szenasi, G; Villa, P; Williamson, T | 1 |
| Andrási, F; Berzsenyi, P; Erdo, F; Német, L | 1 |
| Miura, Y | 1 |
| Agoston, M; Albert, M; Barkóczy, J; Benedek, A; Gacsályi, I; Gigler, G; Hársing, LG; Kapus, G; Kertész, S; Lévay, G; Markó, B; Matucz, E; Móricz, K; Simó, A; Szabó, G; Szénási, G; Vegh, M | 1 |
| Blanchet, PJ; Chase, TN; Konitsiotis, S; Lamers, E; Verhagen, L | 1 |
1 review(s) available for ly 300164 and Disease Models, Animal
| Article | Year |
|---|---|
[A new aspect in the research on antiepileptic drugs].
Topics: Acetamides; Amines; Animals; Anticonvulsants; Benzodiazepines; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Phenylenediamines; Piracetam; Pregabalin; Pregnanolone; Pyrrolidinones; Triazoles | 2007 |
9 other study(ies) available for ly 300164 and Disease Models, Animal
| Article | Year |
|---|---|
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred DBA; Neurons; Olfactory Pathways; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Structure-Activity Relationship; Triazoles | 2003 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzodiazepines; Calcium; Calcium Signaling; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Presynaptic Terminals; Receptors, AMPA; Superoxide Dismutase | 2017 |
Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Cell Death; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Hypoxia; Kainic Acid; Rats; Rats, Long-Evans; Receptors, AMPA; Seizures; Time Factors | 2009 |
The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Topics: Animals; Benzodiazepines; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rose Bengal; Tetrazolium Salts; Time Factors | 2005 |
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; Chickens; Cortical Spreading Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred Strains; Motor Neurons; Nerve Degeneration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Retina; Seizures; Stroke | 2005 |
Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study.
Topics: Animals; Benzodiazepines; Disease Models, Animal; Ischemic Attack, Transient; Male; Monitoring, Physiologic; Motor Activity; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, AMPA; Rotation; Time Factors; Walking | 2006 |
Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Gerbillinae; Male; Membrane Potentials; Mice; Mice, Inbred DBA; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Purkinje Cells; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Seizures; Telencephalon; Time Factors | 2007 |
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzodiazepines; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; Parkinson Disease, Secondary; Piperidines; Receptors, AMPA; Severity of Illness Index | 2000 |